U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. ICF International, LLC - 05/23/2017
  1. Warning Letters

CLOSEOUT LETTER

ICF International, LLC

Recipient:
ICF International, LLC

United States

Issuing Office:

United States

 

  

Black HHS-Blue FDA Logo

 

 

 
5001 Campus Drive
College Park, MD 20740 

May 23, 2017

Brandon Sojka
ICF International, LLC
President and CEO
840 Glynn Street South
Suite 338
Fayetteville, GA 30214

Dear Mr. Sojka,

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 483228, issued November 3, 2015. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Latasha A. Robinson, M.S.
Branch Chief
Dietary Supplement and Labeling
     Assessment Branch
Division of Enforcement
Center for Food Safety and Applied Nutrition

 
Back to Top